Plandai Biotechnology Inc (OTCMKTS:PLPL) Plans to Develop Non-psychoactive Cannabis Extract


Plandai Biotechnology Inc (OTCMKTS:PLPL) is exploring opportunities to develop the first non-psychoactive and full profile cannabis extract.

Chief Operating Officer of Plandai, Callum Cottrell-Duffield said the company is committed to launching a full profile and non-psychoactive cannabis extract. The new product will have a great potential. In the natural state, cannabis does not exhibit psychotropic properties. It is turned into a psychoactive THC through metabolizing THC-B and THC-A precursors in the heating and drying process of cannabis.

The company uses sonoluminescence in the extraction of cannabis and utilizes the heating or drying process when the molecules get stabilized. It is free from side effects. The new cannabis extract will have same levels of bio-availability just like other products that are clinically proven to promote absorption almost 15 times in bloodstream when compared to the generic extracts.

PlandaiPlans to Commence Production in South Africa

The new product is useful for the treatment of neural-related ailments like depression, epilepsy, tremors, and pain. The company is planning to commence the production in South Africa after getting the government nod.

Plandai Scouts for the Treatment of Type 2 Diabetes Using Phytofare

Plandai is discussing the administration of green tea catechins in bioavailable form for the treatment of type 2 diabetes.

It is estimated that 383 million people across the world are suffering from diabetes. Around 90% of the reported cases among the 383 million people are suffering from type 2 diabetes as per the findings in 2013. On an annual basis, 4.9 million deaths are reported due to diabetes in 2014.

The green tea catechins mainly EGCG will exhibit anti-obesity effects ie. by reducing absorption of fats, inhibiting adipocyte differentiation/ proliferation, and reducing fat mass, cholesterol, and triglycerides. It also improves glucose levels. According to a recent study, green tea catechins have cardioprotective, anti-diabetic and anti-obesity properties.

The COO commenting on the development said diabetes is the chief cause of deaths in South Africa. The rate of deaths is increasing in sub-Sahara Africa. Fat rich foods worldwide are also contributing to increased deaths.

The scientific study suggests green tea catechins are highly effective in managing high blood pressure, obesity and type 2 diabetes.


About Author

Leave A Reply